Physician profile
Suzanne Finelli
NPI 1962558494
$1,579.05
in general payments reported to CMS, 2019-2025
11 companies · $635 in 2025
The $635 reported for 2025 was more than what 98% of Registered Nurse First Assistant providers received nationally (typical 2025 total: $41.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $74.59 · 2024: $869 · 2025: $635.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,579.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,579.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $548.59 | 2024-2025 | |
| Exact Sciences Corporation | $292.42 | 2024-2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $291.61 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Pfizer INC. | $113.84 | 2024-2025 | |
| Stryker Corporation | $99.65 | 2024 | Mako |
| Insulet Corporation | $66.77 | 2025 | Omnipod |
| Lilly USA, LLC | $64.96 | 2024-2025 | Zepbound, Mounjaro, Jardiance |
| Glaxosmithkline, LLC. | $38.00 | 2025 | Shingrix |
| Astellas Pharma US INC | $24.90 | 2024 | Veozah |
| Bausch Health US, LLC | $24.46 | 2023 | Aplenzin |
| Azurity Pharmaceuticals, INC. | $13.85 | 2023 | Horizant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Finelli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.